Clinical Trial Update: Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy [Phase 3]

View source ↗

Summary

Phase 3 trial update on nitazoxanide for preventing recurrence of hepatic encephalopathy focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Tanta University | Conditions: Hepatic Encephalopathy | Phase 3 | Status: RECRUITING